Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 11, 2020
Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patientsCoco Dekkers, Mehran Alizadeh Aghdam, Marlies de Graaf, et al.The Journal of Allergy and Clinical Immunology|July 8, 2021
Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clustersDaphne S Bakker, Marlies de Graaf, Stefan Nierkens, et al.Journal of the American Academy of Dermatology|January 17, 2015
Is cardiovascular evaluation necessary prior to and during beta-blocker therapy for infantile hemangiomas?: A cohort studyMartine F Raphael, Corstiaan C Breugem, Florine A E Vlasveld, et al.Allergy|March 19, 2023
Dupilumab-associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysisRoselie Achten, Judith Thijs, Marlot van der Wal, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 16, 2025
Complementary Analysis of Local and Systemic Effects of Dupilumab in Paediatric AD Using Tape Strips and SerumLisa P van der Rijst, Edward F Knol, Nicolaas P A Zuithoff, et al.Acta Dermato-Venereologica|August 12, 2025
Topical Steroid Withdrawal: Perspectives of Dutch Healthcare ProfessionalsFlorence Vroman, Charlotte S Schimmel, Lisa P Van der Rijst, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 19, 2025
Dupilumab-Associated Ocular Surface Disease in Paediatric Atopic Dermatitis Patients: Results From the BioDay RegistryLisa P van der Rijst, Chantal M van Luijk, Sara van der Kamp, et al.Acta Dermato-Venereologica|February 16, 2023
Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay RegistryCeleste M Boesjes, Liana F Van der Gang, Nicolaas P A Zuithoff, et al.JAMA Dermatology|October 18, 2023
Dupilumab-Associated Lymphoid Reactions in Patients With Atopic DermatitisCeleste M Boesjes, Lian F van der Gang, Daphne S Bakker, et al.Allergy|September 24, 2025
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future DirectionsMarjolein S de Bruin-Weller, Celeste M Boesjes, Roselie A Achten, et al.Pageof 6